NIH Schedules Closed Virtual Meetings for Grant Reviews
Published Date: 8/14/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings this fall to review and decide on important grant applications. These meetings affect researchers applying for funding in health and science fields, ensuring their ideas and personal info stay private. Mark your calendar for September through November 2025—these reviews help decide who gets research money next!
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Closed NIH review — Sept 9, 2025
On September 9, 2025, the NIH Center for Scientific Review will hold a closed virtual meeting to review grant applications for Complementary and Integrative Health Interventions and Outcomes. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of applicants; the reviews help decide who receives NIH research funding.
MIRA grant review — Nov 6-7, 2025
On November 6-7, 2025, a Center for Scientific Review Special Emphasis Panel will virtually review and evaluate PAR-22-180 Maximizing Investigators' Research Award (MIRA) grant applications. The meeting will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential commercial information and personal data; the panel's evaluations will help determine which investigators receive MIRA funding.
Small business grant reviews — Nov 20-21, 2025
On November 20-21, 2025, the NIH Center for Scientific Review will hold a closed virtual panel to review Small Business grant applications for Disease Management, Risk Prevention, and Health Behavior Change. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential commercial information and personal data; the reviews will help decide which small businesses receive NIH research funding.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14964, Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a closed virtual meeting on August 19, 2026, to review neuroscience career development grant applications. This meeting is private to protect sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as funding decisions could impact their projects and careers.
Previous / Next Documents
Previous: 2025-15429, Certain Exercise Equipment and Subassemblies Thereof; Notice of Issuance of a General Exclusion Order and a Limited Exclusion Order; Termination of the Investigation
The U.S. International Trade Commission is blocking certain exercise equipment and parts that break specific patents from coming into the country. This affects importers selling these products and means some shipments will be stopped to protect patent owners. The investigation is now over, so these new rules kick in right away to keep things fair and protect innovation.
Next: 2025-15431, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings this fall to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide which science projects get funding. If you’re a researcher waiting on grant news, these dates in September and October 2025 are key moments for your proposals.